Cigna Group $CI Stock Bought by StoneX Group Inc.

StoneX Group Inc. lifted its stake in shares of Cigna Group (NYSE:CI) by 40.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,874 shares of the health services provider’s stock after buying an additional 1,981 shares during the quarter. StoneX Group Inc.’s holdings in Cigna Group were worth $1,876,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Assetmark Inc. boosted its position in shares of Cigna Group by 10.0% in the 1st quarter. Assetmark Inc. now owns 65,662 shares of the health services provider’s stock valued at $17,515,000 after purchasing an additional 5,963 shares during the period. Mystic Asset Management Inc. purchased a new position in Cigna Group during the 2nd quarter worth approximately $2,808,000. KBC Group NV increased its position in Cigna Group by 6.4% during the second quarter. KBC Group NV now owns 380,034 shares of the health services provider’s stock worth $104,768,000 after buying an additional 22,978 shares during the period. Nykredit A S acquired a new position in Cigna Group during the second quarter worth approximately $15,300,000. Finally, Sanctuary Advisors LLC acquired a new position in Cigna Group during the second quarter worth approximately $11,043,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Buying and Selling

In other news, insider Nicole S. Jones sold 2,677 shares of the firm’s stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the sale, the insider directly owned 25,880 shares of the company’s stock, valued at $7,236,306.80. This trade represents a 9.37% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the firm’s stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the sale, the insider directly owned 5,053 shares of the company’s stock, valued at $1,435,304.65. This represents a 10.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by insiders.

Cigna Group Stock Up 0.0%

CI stock opened at $293.66 on Monday. Cigna Group has a one year low of $255.53 and a one year high of $318.05. The stock has a market capitalization of $77.60 billion, a PE ratio of 12.96, a price-to-earnings-growth ratio of 1.01 and a beta of 0.25. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.74 and a current ratio of 0.74. The company has a fifty day moving average of $285.81 and a 200-day moving average of $282.17.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, November 5th. The health services provider reported $7.98 earnings per share for the quarter, beating the consensus estimate of $7.52 by $0.46. Cigna Group had a net margin of 2.09% and a return on equity of 19.57%. The business had revenue of $73.79 billion for the quarter, compared to the consensus estimate of $72.64 billion. During the same quarter in the previous year, the firm earned $7.83 earnings per share. The business’s quarterly revenue was up 5.6% compared to the same quarter last year. As a group, analysts expect that Cigna Group will post 30.62 EPS for the current year.

Cigna Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Shareholders of record on Thursday, December 3rd will be issued a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend is Thursday, December 3rd. Cigna Group’s payout ratio is currently 27.54%.

Key Cigna Group News

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Third-quarter adjusted earnings were $7.98 per share, ahead of estimates, while revenue rose 6% to about $73.8 billion and also exceeded consensus. Strength in Cigna Healthcare and a favorable pharmacy benefit mix supported results. Cigna Q3 Earnings and Revenues Beat Estimates
• Positive Sentiment: Management raised its 2026 adjusted earnings outlook to at least $30.60 per share. Employer medical growth is expected to help offset Cigna’s exit from the ACA individual market. Cigna lifts 2026 outlook
• Positive Sentiment: At its investor event, Cigna outlined a multi-year $3 billion modernization and productivity program, targeting 10%–14% adjusted EPS growth annually and approximately $50 billion in cumulative operating cash flow through 2030. Cigna raises 2026 outlook after strong quarter
• Neutral Sentiment: Analyst views remain supportive: Cantor Fitzgerald reaffirmed Overweight with a $340 target. Guggenheim kept a Buy rating but lowered its target to $347 from $361, tempering the positive signal. Guggenheim ratings
• Negative Sentiment: Despite higher adjusted earnings, reported GAAP net income fell to $1.4 billion from $1.87 billion a year earlier. The ACA individual-market exit also brings transition and execution risks, even as employer business growth is expected to offset it. Cigna Group lifts outlook as revenue climbs

Analysts Set New Price Targets

CI has been the subject of a number of research reports. Barclays boosted their price objective on Cigna Group from $304.00 to $310.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. Guggenheim lowered their target price on shares of Cigna Group from $361.00 to $347.00 and set a “buy” rating on the stock in a research report on Friday. UBS Group reaffirmed a “buy” rating on shares of Cigna Group in a report on Thursday, October 1st. Wells Fargo & Company upped their price target on shares of Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a research report on Friday, July 31st. Finally, Jefferies Financial Group downgraded shares of Cigna Group from a “buy” rating to a “hold” rating and reduced their price target for the company from $336.00 to $307.00 in a research report on Tuesday, August 4th. Fourteen research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat.com, Cigna Group has a consensus rating of “Moderate Buy” and an average price target of $335.70.

Cigna Group Company Profile

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members.

Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.

The company serves customers in the United States and select international markets.